New diabetes pill study tracks weight and sugar control
NCT ID NCT06269120
First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study follows about 470 adults with type 2 diabetes who are starting oral semaglutide as part of their regular care. Researchers will track changes in blood sugar (HbA1c) and body weight over about 6 months. The goal is to see how well the medicine works in everyday practice when prescribed by heart doctors or diabetes specialists.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Siklósi Kórház, Diabetológia
RECRUITINGSiklós, 7801, Hungary
Conditions
Explore the condition pages connected to this study.